Novavax
NVAX
#5259
Rank
NZ$2.57 B
Marketcap
NZ$15.85
Share price
1.07%
Change (1 day)
23.01%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): NZ$0.65 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$1.02 Billion. In 2024 the company made an earning of -NZ$0.27 Billion, an increase over its 2023 earnings that were of -NZ$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.65 B-349.52%
2024 -NZ$0.27 Billion-70.39%
2023 -NZ$0.89 Billion-16.59%
2022 -NZ$1.07 Billion-62.58%
2021 -NZ$2.84 Billion320.54%
2020 -NZ$0.68 Billion234.22%
2019 -NZ$0.21 Billion-30.17%
2018 -NZ$0.29 Billion1.69%
2017 -NZ$0.29 Billion-36.44%
2016 -NZ$0.45 Billion70.4%
2015 -NZ$0.27 Billion89.27%
2014 -NZ$0.14 Billion59.83%
2013 -NZ$86.79 Million81.9%
2012 -NZ$47.71 Million50.33%
2011 -NZ$31.74 Million
2009 -NZ$62.64 Million8.8%
2008 -NZ$57.57 Million18.01%
2007 -NZ$48.79 Million18.33%
2006 -NZ$41.23 Million168.31%
2005 -NZ$15.37 Million-62.51%
2004 -NZ$40.99 Million52.4%
2003 -NZ$26.9 Million-28.21%
2002 -NZ$37.47 Million
2000 -NZ$21.35 Million177%
1999 -NZ$7.71 Million-11.54%
1998 -NZ$8.72 Million10.64%
1997 -NZ$7.88 Million-9.62%
1996 -NZ$8.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.39 B 4,260.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.85 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.93 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$15.61 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$0.43 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.43 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.61 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.62 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$11.09 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.27 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA